Ryan Parr is the Chief Scientific Officer and the Vice President of research and development for Genesis Genomics Inc., of Thunder Bay, Ontario, Canada. He has utilized his academic research background in the area of mitochondrial DNA (mtDNA) to develop the company’s successful commercial research platform and leading-edge biomarker-discovery capabilities. He began his research career at The University of Utah, in the Department of Cellular, Viral, and Molecular Biology. He has worked on projects including nuclear differentiation within eukaryotic cells, mechanisms of viral infections, recovery and sequencing of mtDNA extracted from the skeletal remains of ancient Egyptian populations, and the use of mtDNA for the identification of unclaimed victims from the 1912 Titanic disaster. Previously, as a Senior Research Specialist in the Department of Hematology and Oncology at The University of Utah Health Sciences Center, he worked on the problem of cancer resistance to drug therapy.
Biography Updated on 13 March 2012